Contemporary OB/GYN founder receives lifetime achievement award
Contemporary OB/GYN congratulates Founding Editor John T. Queenan, MD, on the lifetime achievement award presented to him at the 9th Philadelphia Prenatal Conference. Held June 8 to 10 in the city for which it was named, the event was jointly sponsored by the American College of Obstetricians and Gynecologists and the Philadelphia Prenatal Diagnosis Institute/The Philadelphia pregnancy, Genetics and Ultrasound Center.
Contemporary OB/GYN congratulates Founding Editor John T. Queenan, MD, on the lifetime achievement award presented to him at the 9th Philadelphia Prenatal Conference. Held June 8 to 10 in the city for which it was named, the event was jointly sponsored by the American College of Obstetricians and Gynecologists and the Philadelphia Prenatal Diagnosis Institute/The Philadelphia pregnancy, Genetics and Ultrasound Center.
During the conference, internationally and nationally renowned experts presented updates on current screening and testing recommendations and cutting-edge information on advances in in obstetrics, maternal-fetal medicine, prenatal genetics and prenatal ultrasound diagnosis. Included were lectures on topics such as preimplantation genetic screening and diagnosis, the future of fetal cardiovascular imaging, and re-engineering fetal monitoring as well as hands-on practice with fetal ultrasound.
A presentation on Rh alloimmunization was given by Dr. Queenan, whose illustrious career has included pioneering work in prevention and management of the disease and research in ultrasound and fetal physiology. Also honored with a lifetime achievement award at the event was Maria New, MD, of the Icahn School of Medicine at Mount Sinai in New York, who gave a presentation on the added value of noninvasive prenatal diagnosis for congenital adrenal hyperplasia.
S4E1: New RNA platform can predict pregnancy complications
February 11th 2022In this episode of Pap Talk, Contemporary OB/GYN® sat down with Maneesh Jain, CEO of Mirvie, and Michal Elovitz, MD, chief medical advisor at Mirvie, a new RNA platform that is able to predict pregnancy complications by revealing the biology of each pregnancy. They discussed recently published data regarding the platform's ability to predict preeclampsia and preterm birth.
Listen
One-hour glucose tolerance test: Improved prediction of diabetes risk
March 4th 2025A new study finds that a 1-hour oral glucose tolerance test is more effective than the traditional 2-hour test in predicting future diabetes risk, especially for women with a history of gestational diabetes.
Read More
